Clinical Trials Browser

Phase 1 × Hearing Loss × Sarcoma × Clear all

NCT02094625 2023-04-18

NAC to Prevent Cisplatin-induced Hearing Loss

Phase 1 Completed

GastrointestinalSarcoma

Liver Neoplasms, Osteosarcoma, Neuroectodermal Tumors, Primitive, Hearing Loss